Valuation : Healthconn Corp.

Market Cap 816M 25.74M 22.16M 20.81M 19M 35.69M 2.45B 35.94M 247M 95.95M 1.24B 96.65M 94.55M 4.11B P/E 2024
43.8x
P/E 2025 108x
Enterprise Value 697M 21.98M 18.93M 17.77M 16.22M 30.48M 2.09B 30.69M 211M 81.93M 1.06B 82.54M 80.74M 3.51B EV / Sales 2024
0.41x
EV / Sales 2025 0.7x
Free-Float
58.01%
Yield 2024
3.81%
Yield 2025 0.74%
1 day-2.39%
1 week-2.13%
Current month-1.08%
1 month-0.54%
3 months-8.00%
6 months-10.68%
Current year-8.23%
1 week 17.65
Extreme 17.65
19.4
1 month 17.25
Extreme 17.25
19.4
Current year 17.25
Extreme 17.25
24.4
1 year 17.25
Extreme 17.25
25
3 years 16.9
Extreme 16.9
31.25
5 years 16.9
Extreme 16.9
54.6
10 years 16.9
Extreme 16.9
247.02
Manager TitleAgeSince
Chief Executive Officer - 2023-12-20
Director of Finance/CFO - 2018-12-20
Comptroller/Controller/Auditor - 2021-03-21
Director TitleAgeSince
Director/Board Member - 2017-12-26
Director/Board Member - 2020-06-21
Director/Board Member - 2022-06-16
Change 5-day change 1-year change 3-year change Capi.($)
-2.39%-2.13%-21.20%-39.57% 27M
+0.26%-0.89%-18.52%-29.24% 188M
-1.72%-3.56%-47.66%-52.58% 160M
Average -1.28%-3.20%-29.13%-40.46% 125.3M
Weighted average by Cap. -0.78%-2.47%-31.15%-39.94%

Financials

2024 2025
Net sales 1.25B 39.52M 34.03M 31.95M 29.17M 54.79M 3.76B 55.19M 379M 147M 1.91B 148M 145M 6.31B 1.13B 35.67M 30.71M 28.83M 26.32M 49.45M 3.39B 49.8M 342M 133M 1.72B 134M 131M 5.7B
Net income 19.23M 606K 522K 490K 447K 841K 57.69M 847K 5.81M 2.26M 29.26M 2.28M 2.23M 96.87M 8.39M 265K 228K 214K 195K 367K 25.19M 370K 2.54M 987K 12.77M 994K 972K 42.29M
Net Debt -317M -10.01M -8.62M -8.09M -7.39M -13.88M -953M -13.98M -95.91M -37.31M -483M -37.59M -36.77M -1.6B -119M -3.76M -3.24M -3.04M -2.77M -5.21M -358M -5.25M -36.02M -14.01M -181M -14.12M -13.81M -601M
Logo Healthconn Corp.
HEALTHCONN CORP. is a Taiwan-based Company mainly engaged in the provision of disease prevention and treatment services. The Company is engaged in the provision of precisely prevent medical integration services, molecular biology testing programs and accurate diagnostic testing services. The precisely prevent medical integration services include precisely prevention, disease management and health promotion services. The molecular bioassay services include food safety testing and functional medical testing services. The accurate diagnostic testing services include molecular testing and clinical microbiological testing services, as well as the development and operation of medical health institutions. The Company is also engaged in the medical equipment sale business. The Company operates in the Taiwan market as well as in the mainland China market.
Employees
205
Date Price Change Volume
26-08-31 NT$18.00 -4.51% 25,040
26-08-28 NT$18.85 -0.79% 7,030
26-08-27 NT$19.00 -0.52% 20
26-08-26 NT$19.10 -1.55% 15,251
26-08-25 NT$19.40 +3.19% 22,309
  1. Stock Market
  2. Stocks
  3. 6665 Stock